481 related articles for article (PubMed ID: 31306117)
21. Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.
Racine AM; Koscik RL; Berman SE; Nicholas CR; Clark LR; Okonkwo OC; Rowley HA; Asthana S; Bendlin BB; Blennow K; Zetterberg H; Gleason CE; Carlsson CM; Johnson SC
Brain; 2016 Aug; 139(Pt 8):2261-74. PubMed ID: 27324877
[TBL] [Abstract][Full Text] [Related]
22. Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.
Reijs BLR; Ramakers IHGB; Köhler S; Teunissen CE; Koel-Simmelink M; Nathan PJ; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Vandenberghe R; Johannsen P; Blackwell A; Vanderstichele H; Verhey F; Visser PJ
J Alzheimers Dis; 2017; 60(3):1119-1128. PubMed ID: 28984585
[TBL] [Abstract][Full Text] [Related]
23. Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.
Marizzoni M; Ferrari C; Macis A; Jovicich J; Albani D; Babiloni C; Cavaliere L; Didic M; Forloni G; Galluzzi S; Hoffmann KT; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Pizzini F; Rossini PM; Salvatore M; Schönknecht P; Soricelli A; Del Percio C; Hensch T; Hegerl U; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
J Alzheimers Dis; 2019; 69(1):49-58. PubMed ID: 30958351
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.
Dong A; Toledo JB; Honnorat N; Doshi J; Varol E; Sotiras A; Wolk D; Trojanowski JQ; Davatzikos C;
Brain; 2017 Mar; 140(3):735-747. PubMed ID: 28003242
[TBL] [Abstract][Full Text] [Related]
25. Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures.
Falgàs N; Ruiz-Peris M; Pérez-Millan A; Sala-Llonch R; Antonell A; Balasa M; Borrego-Écija S; Ramos-Campoy O; Augé JM; Castellví M; Tort-Merino A; Olives J; Fernández-Villullas G; Blennow K; Zetterberg H; Bargalló N; Lladó A; Sánchez-Valle R
Hum Brain Mapp; 2020 Jun; 41(8):2004-2013. PubMed ID: 31944489
[TBL] [Abstract][Full Text] [Related]
26. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
27. Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease.
Skillbäck T; Kornhuber J; Blennow K; Zetterberg H; Lewczuk P;
J Alzheimers Dis; 2019; 69(2):551-559. PubMed ID: 31104027
[TBL] [Abstract][Full Text] [Related]
28. Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.
Tucholka A; Grau-Rivera O; Falcon C; Rami L; Sánchez-Valle R; Lladó A; Gispert JD; Molinuevo JL;
J Alzheimers Dis; 2018; 61(4):1575-1587. PubMed ID: 29376852
[TBL] [Abstract][Full Text] [Related]
29. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
[TBL] [Abstract][Full Text] [Related]
30. Neurofilament relates to white matter microstructure in older adults.
Moore EE; Hohman TJ; Badami FS; Pechman KR; Osborn KE; Acosta LMY; Bell SP; Babicz MA; Gifford KA; Anderson AW; Goldstein LE; Blennow K; Zetterberg H; Jefferson AL
Neurobiol Aging; 2018 Oct; 70():233-241. PubMed ID: 30036759
[TBL] [Abstract][Full Text] [Related]
31. Fixel-Based Analysis Reveals Tau-Related White Matter Changes in Early Stages of Alzheimer's Disease.
Ahmadi K; Pereira JB; van Westen D; Pasternak O; Zhang F; Nilsson M; Stomrud E; Spotorno N; Hansson O
J Neurosci; 2024 May; 44(18):. PubMed ID: 38565289
[TBL] [Abstract][Full Text] [Related]
32. Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.
Hake A; Trzepacz PT; Wang S; Yu P; Case M; Hochstetler H; Witte MM; Degenhardt EK; Dean RA;
Alzheimers Dement; 2015 Aug; 11(8):986-93. PubMed ID: 25916563
[TBL] [Abstract][Full Text] [Related]
33. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.
Fiford CM; Manning EN; Bartlett JW; Cash DM; Malone IB; Ridgway GR; Lehmann M; Leung KK; Sudre CH; Ourselin S; Biessels GJ; Carmichael OT; Fox NC; Cardoso MJ; Barnes J;
Hippocampus; 2017 Mar; 27(3):249-262. PubMed ID: 27933676
[TBL] [Abstract][Full Text] [Related]
34. Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.
Al-Janabi OM; Brown CA; Bahrani AA; Abner EL; Barber JM; Gold BT; Goldstein LB; Murphy RR; Nelson PT; Johnson NF; Shaw LM; Smith CD; Trojanowski JQ; Wilcock DM; Jicha GA
J Alzheimers Dis; 2018; 66(3):1095-1104. PubMed ID: 30400099
[TBL] [Abstract][Full Text] [Related]
35. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease.
Skouras S; Falcon C; Tucholka A; Rami L; Sanchez-Valle R; Lladó A; Gispert JD; Molinuevo JL
Neuroimage Clin; 2019; 22():101777. PubMed ID: 30913531
[TBL] [Abstract][Full Text] [Related]
37. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S
J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470
[TBL] [Abstract][Full Text] [Related]
38. Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment.
Amlien IK; Fjell AM
Neuroscience; 2014 Sep; 276():206-15. PubMed ID: 24583036
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease.
Reas ET; Hagler DJ; White NS; Kuperman JM; Bartsch H; Cross K; Loi RQ; Balachandra AR; Meloy MJ; Wierenga CE; Galasko D; Brewer JB; Dale AM; McEvoy LK
Alzheimers Res Ther; 2017 Aug; 9(1):55. PubMed ID: 28764771
[TBL] [Abstract][Full Text] [Related]
40. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.
Spallazzi M; Barocco F; Michelini G; Immovilli P; Taga A; Morelli N; Ruffini L; Caffarra P
Acta Neurol Belg; 2019 Sep; 119(3):445-452. PubMed ID: 30847669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
